Loading...
Please wait, while we are loading the content...
Similar Documents
Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Prasad, Abhiram Quyyumi, Arshed A. |
| Copyright Year | 2004 |
| Abstract | Activation of the renin-angiotensin system (RAS) occurs in many cardiovascular disorders, and its modulation with angiotensin-converting enzyme (ACE) inhibitors is now established therapy for hypertension, left ventricular dysfunction, diabetic nephropathy, and atherosclerosis. More recently, angiotensin type 1 receptor blockers (ARBs) have shown similar promise.1,2 Research is currently focused on the role of the RAS in the metabolic syndrome (MetS), a disorder characterized primarily by insulin resistance that has emerged as a major risk factor for cardiovascular disease.3 Here, we review how cross talk between angiotensin II (AII) and insulin signaling contributes to the pathophysiology of the MetS and raises the potential for therapeutic use of angiotensin antagonists in its management. |
| Starting Page | 87 |
| Ending Page | 106 |
| Page Count | 20 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://circ.ahajournals.org/content/circulationaha/110/11/1507.full.pdf?download=true |
| PubMed reference number | 15364819v1 |
| Volume Number | 110 |
| Issue Number | 11 |
| Journal | Circulation |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Angiotensin II Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Angiotensins Arteriopathic disease Atherogenesis Atherosclerosis Cardiovascular Diseases Cerebrovascular accident Coronary Artery Disease Diabetes Mellitus Diabetes Mellitus, Non-Insulin-Dependent Diabetic Nephropathy Elfacos OW 100 Heart failure Hyperlipidemia Hypertensive disease Insulin Resistance Kidney Diseases Metabolic Syndrome X Metastatic Neoplasm NLRP3 gene Receptor, Angiotensin, Type 1 Renin-angiotensin system Thrombophilia Ventricular Dysfunction Ventricular Dysfunction, Left glucose metabolism |
| Content Type | Text |
| Resource Type | Article |